Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CNTA
Stock Latest News
Ratings
Promising Outlook for Centessa Pharmaceuticals: ORX750’s Potential Differentiation and Efficacy Drive Buy Rating
17d ago
CNTA
Premium
The Fly
Alkermes narcolepsy trial results ‘encouraging’ for Centessa, says Leerink
18d ago
ALKS
CNTA
Premium
The Fly
Centessa initiated with a Buy at Truist
18d ago
CNTA
Premium
Ratings
Positive Market Outlook for Centessa Pharmaceuticals Driven by Promising Developments in Orexin Agonist Class
24d ago
CNTA
Premium
Ratings
Optimistic Buy Rating for Centessa Pharmaceuticals Driven by Orexin Agonist Market Potential and Positive Safety Profile
24d ago
CNTA
Premium
Ratings
Centessa Pharmaceuticals Positioned for Leadership in Orexin Agonist Market with Promising ORX750 Candidate
1M ago
CNTA
Premium
Company Announcements
Centessa Pharmaceuticals Approves Key Resolutions at AGM
2M ago
8K
CNTA
Premium
Company Announcements
Centessa Pharmaceuticals Gains FDA Clearance for ORX142 Study
2M ago
8K
CNTA
Premium
The Fly
Centessa announces clearance of IND for ORX142
2M ago
CNTA
Premium
Ratings
Centessa Pharmaceuticals: Buy Rating Affirmed on Promising Orexin Agonist Program and Innovative Trial Design
2M ago
CNTA
Premium
Ratings
Centessa Pharmaceuticals: Promising Orexin Drug Pipeline and Strong Market Potential Drive Buy Rating
2M ago
CNTA
Premium
Company Announcements
Centessa Pharmaceuticals Appoints New Chief Accounting Officer
2M ago
8K
CNTA
Premium
The Fly
Centessa initiated with a Buy at Needham
2M ago
CNTA
Premium
Ratings
Positive Outlook on Centessa Pharmaceuticals Driven by ORX750’s Promising Potential and Market Growth
2M ago
CNTA
Premium
Company Announcements
Centessa Pharmaceuticals Advances OX2R Agonist Pipeline
3M ago
CNTA
Premium
The Fly
Centessa reports Q1 EPS (20c) vs (38c) last year
3M ago
CNTA
Premium
The Fly
Trump announces trade deal, BoE lowers Bank Rate: Morning Buzz
3M ago
Z
SN
Premium
The Fly
Uber downgraded, Rockwell Automation upgraded: Wall Street’s top analyst calls
3M ago
ADM
AWR
Premium
The Fly
Centessa initiated with a Buy at Chardan
3M ago
CNTA
Premium
Ratings
Centessa Pharmaceuticals’ ORX750: Promising Developments and Buy Rating by David Risinger
4M ago
CNTA
Premium
The Fly
Centessa initiated with an Overweight at Piper Sandler
4M ago
CNTA
Premium
Ratings
Centessa Pharmaceuticals: Promising Potential in Neuropsychiatric Disorders with ORX750 and Orexin Agonist Pipeline
4M ago
CNTA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
